Whole genome off-target evaluation method and application thereof

CN121963874APending Publication Date: 2026-05-01EPIGENIC THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
EPIGENIC THERAPEUTICS INC
Filing Date
2024-10-22
Publication Date
2026-05-01

Smart Images

  • Figure BDA0005097843550000051
    Figure BDA0005097843550000051
  • Figure BDA0005097843550000061
    Figure BDA0005097843550000061
  • Figure BDA0005097843550000062
    Figure BDA0005097843550000062
Patent Text Reader

Abstract

The invention provides a method for evaluating genome off-target, which comprises the following steps: carrying out methylation and histone modification on a targeting site by using an epigenetic editing tool, and carrying out whole genome transcriptome sequencing, whole genome methylation sequencing and CUTamp on the modified gene, carrying out Tag sequencing, wherein CUTamp is used as a template; tag sequencing comprises H3K4me3, H3K9ac, H3K27ac, H3K9me3 and H3K27me3 histone modification detection, and a whole transcriptome quantitative result, a whole genome methylation level quantitative result and CUTamp are obtained; tag peak abundance quantitative results, determining a target site change map, and determining methylation and histone change directions; and finally, carrying out difference analysis on the sequencing result to determine off-target information.
Need to check novelty before this filing date? Find Prior Art